Hydroquinone

氢醌

Report date: 2023/02/27 17:44:26
NME

Base Information

Drug NameHydroquinone
Drug Alias Name1,4-Benzenediol对苯二酚HidrokinonHydrochinonumQuinol +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosinase-related protein 1 inhibitors
TargetsTyrosinase-related protein 1
Therapy Area/IndicationsLentigoMelanosisPigmentation Disorders
Global Approved IndicationsLentigoMelanosisPigmentation Disorders
Approved Indications in ChinaLentigoMelanosisPigmentation Disorders
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1984/06/22
Country/TerritoryCanadaUnited KingdomSpain +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMesoestetic Pharma Group, Sl
China Registration ClassN/A

Develop Information

Active IndicationsLentigoMelanosisPigmentation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeD11AX11